{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:02:41Z","timestamp":1793419361510,"version":"4.5.0"},"reference-count":89,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Deep brain stimulation (DBS) is an established therapy for motor symptom management in Parkinson\u2019s disease (PD), yet emerging evidence suggests that its effects may extend beyond functional circuit modulation to include cellular and molecular mechanisms with potential neuroprotective significance. This review synthesizes current evidence on the neuroprotective mechanisms of DBS, with an emphasis on preclinical and clinical studies that highlight its effects on neuronal survival, trophic support, oxidative stress, inflammation, synaptic plasticity, and network homeostasis. Preclinical data indicate that DBS reduces dopaminergic neuron degeneration, enhances brain-derived neurotrophic factor (BDNF) signaling, preserves mitochondrial function, attenuates neuroinflammation, and fosters synaptic remodeling. Clinical studies provide convergent, though less definitive, evidence from imaging, fluid biomarkers, and long-term outcomes supporting potential disease-modifying effects. These findings underscore a shift in the conceptualization of DBS from purely symptomatic relief toward modulation of underlying pathogenic processes. DBS holds promise as a neuroprotective therapy for PD, but critical gaps remain in validating these mechanisms in patients. Future directions include the development of biomarker-driven longitudinal studies, refinement of adaptive stimulation strategies, integration with adjunctive disease-modifying strategies, and exploration of personalized approaches based on molecular and network signatures. By bridging mechanistic understanding with translational innovation, DBS may evolve into a precision therapy capable of altering the progression trajectory of PD.<\/jats:p>","DOI":"10.3390\/biomedicines14010019","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:35:27Z","timestamp":1766392527000},"page":"19","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cellular and Molecular Mechanisms of Neuroprotection in Deep Brain Stimulation for Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3142-6022","authenticated-orcid":false,"given":"Aiswarya","family":"Nag","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of Florida, Gainesville, FL 32608, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-1501","authenticated-orcid":false,"given":"Siddharth","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD 20201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-4080","authenticated-orcid":false,"given":"Brandon","family":"Lucke-Wold","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Florida, Gainesville, FL 32608, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"114684","DOI":"10.1016\/j.expneurol.2024.114684","article-title":"Insights into neuroinflammatory mechanisms of deep brain stimulation in Parkinson\u2019s disease","volume":"374","author":"Eser","year":"2024","journal-title":"Exp. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/acn3.682","article-title":"Deep brain stimulation: Potential for neuroprotection","volume":"6","author":"McKinnon","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/ejn.14088","article-title":"Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson\u2019s disease: Central role of disease severity","volume":"49","author":"Stefani","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40035-023-00390-w","article-title":"Neuronal and synaptic adaptations underlying the benefits of deep brain stimulation for Parkinson\u2019s disease","volume":"12","author":"Xu","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Nordi, T.M., Gounella, R.H., Luppe, M., Junior, J.N.S., Fonoff, E.T., Colombari, E., Romero, M.A., and Carmo, J.P.P.D. (2022). Low-Noise Amplifier for Deep-Brain Stimulation (DBS). Electronics, 11.","DOI":"10.3390\/electronics11060939"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.conb.2003.11.001","article-title":"Deep brain stimulation for Parkinson\u2019s disease","volume":"13","author":"Benabid","year":"2003","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nrneurol.2017.105","article-title":"Insights into the mechanisms of deep brain stimulation","volume":"13","author":"Ashkan","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e9575","DOI":"10.15252\/emmm.201809575","article-title":"Cellular, molecular, and clinical mechanisms of action of deep brain stimulation-a systematic review on established indications and outlook on future developments","volume":"11","author":"Jakobs","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11065-022-09540-9","article-title":"Deep Brain Stimulation in Parkinson Disease: A Meta-analysis of the Long-term Neuropsychological Outcomes","volume":"33","author":"Bucur","year":"2023","journal-title":"Neuropsychol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/bcpt.14042","article-title":"Biomarkers of Parkinson\u2019s disease in perspective of early diagnosis and translation of neurotrophic therapies","volume":"135","author":"Tuominen","year":"2024","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.27360","article-title":"Disease Modification in Parkinson\u2019s Disease: Current Approaches, Challenges, and Future Considerations","volume":"33","author":"Lang","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Sarkar, S., Raymick, J., and Imam, S. (2016). Neuroprotective and Therapeutic Strategies against Parkinson\u2019s Disease: Recent Perspectives. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060904"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/s41598-024-53355-y","article-title":"The significance of glial cell line-derived neurotrophic factor analysis in Progressive Supranuclear Palsy","volume":"14","author":"Alster","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s13311-013-0211-8","article-title":"Epigenetic landscape of Parkinson\u2019s disease: Emerging role in disease mechanisms and therapeutic modalities","volume":"10","author":"Tarannum","year":"2013","journal-title":"Neurotherapeutics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbadis.2013.09.007","article-title":"Mitochondria-targeted antioxidants for treatment of Parkinson\u2019s disease: Preclinical and clinical outcomes","volume":"1842","author":"Jin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gogna, T., Housden, B.E., and Houldsworth, A. (2024). Exploring the Role of Reactive Oxygen Species in the Pathogenesis and Pathophysiology of Alzheimer\u2019s and Parkinson\u2019s Disease and the Efficacy of Antioxidant Treatment. Antioxidants, 13.","DOI":"10.3390\/antiox13091138"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4103\/1673-5374.300980","article-title":"Oxidative stress factors in Parkinson\u2019s disease","volume":"16","author":"Dorszewska","year":"2021","journal-title":"Neural Regen. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.brs.2024.02.005","article-title":"Reduction of alpha-synuclein oligomers in preclinical models of Parkinson\u2019s disease by electrical stimulation in vitro and deep brain stimulation in vivo","volume":"17","author":"Lee","year":"2024","journal-title":"Brain Stimul."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","article-title":"A-synuclein misfolding and Parkinson\u2019s disease","volume":"1822","author":"Breydo","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-2015-2012","article-title":"Role of the unfolded protein response in the pathogenesis of Parkinson\u2019s disease","volume":"75","author":"Varma","year":"2015","journal-title":"Acta Neurobiol. Exp."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1159\/000350082","article-title":"Proteomic analysis of the cerebrospinal fluid of Parkinson\u2019s disease patients pre- and post-deep brain stimulation","volume":"31","author":"Wang","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo, B., Caridade-Silva, R., Soares-Guedes, C., Martins-Macedo, J., Gomes, E.D., Monteiro, S., and Teixeira, F.G. (2022). Neuroinflammation and Parkinson\u2019s Disease-From Neurodegeneration to Therapeutic Opportunities. Cells, 11.","DOI":"10.3390\/cells11182908"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","article-title":"Contributions of central and systemic inflammation to the pathophysiology of Parkinson\u2019s disease","volume":"62","author":"Collins","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/nan.12297","article-title":"Review: Parkinson\u2019s disease: From synaptic loss to connectome dysfunction","volume":"42","author":"Bellucci","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Toader, C., Tataru, C.P., Munteanu, O., Serban, M., Covache-Busuioc, R.A., Ciurea, A.V., and Enyedi, M. (2024). Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer\u2019s, Parkinson\u2019s, and ALS. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252312613"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41531-024-00668-4","article-title":"Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson\u2019s disease","volume":"10","author":"Chen","year":"2024","journal-title":"NPJ Park. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1472-9288(03)00003-7","article-title":"Might Deep Brain Stimulation of the Subthalamic Nucleus Be Neuroprotective in Patients with Parkinson\u2019s Disease?","volume":"2","author":"Benabid","year":"2003","journal-title":"Thalamus Relat. Syst."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mds.27280","article-title":"AZSAND Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson\u2019s disease","volume":"33","author":"Pal","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_30","first-page":"4072","article-title":"Effect of deep brain stimulation on substantia nigra neurons in a rat model of Parkinson\u2019s disease","volume":"125","author":"Wu","year":"2012","journal-title":"Chin. Med. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ana.24947","article-title":"Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T \u03b1-synuclein Parkinson\u2019s disease rat model","volume":"81","author":"Musacchio","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brs.2018.08.015","article-title":"The neuroprotective effect of deep brain stimulation at nucleus basalis of Meynert in transgenic mice with Alzheimer\u2019s disease","volume":"12","author":"Huang","year":"2019","journal-title":"Brain Stimul."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00702-017-1736-5","article-title":"Basal ganglia, movement disorders and deep brain stimulation: Advances made through non-human primate research","volume":"125","author":"Wichmann","year":"2018","journal-title":"J. Neural Transm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/brain\/awm137","article-title":"Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys","volume":"130","author":"Wallace","year":"2007","journal-title":"Brain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"26259","DOI":"10.1073\/pnas.1902300116","article-title":"Understanding Parkinson\u2019s disease and deep brain stimulation: Role of monkey models","volume":"116","author":"Vitek","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(99)00260-5","article-title":"Leads for the development of neuroprotective treatment in Parkinson\u2019s disease and brain imaging methods for estimating treatment efficacy","volume":"375","author":"Stoof","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00701-012-1610-z","article-title":"Perfusion brain SPECT in assessing motor improvement after deep brain stimulation in Parkinson\u2019s disease","volume":"155","author":"Paschali","year":"2013","journal-title":"Acta Neurochir."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.wneu.2018.11.247","article-title":"A Review of Biomarkers Use in Parkinson with Deep Brain Stimulation: A Successful Past Promising a Bright Future","volume":"123","author":"Mugge","year":"2019","journal-title":"World Neurosurg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41531-024-00808-w","article-title":"Significance of neurodegeneration and neuroplasticity serum biomarkers in Parkinson\u2019s disease patients treated with subthalamic stimulation","volume":"10","author":"Sanmartino","year":"2024","journal-title":"NPJ Park. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1096\/fj.201802628R","article-title":"Post mortem examination of Parkinson\u2019s disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus","volume":"33","author":"Mallach","year":"2019","journal-title":"FASEB J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ana.23890","article-title":"Timing of deep brain stimulation in Parkinson disease: A need for reappraisal?","volume":"73","author":"deSouza","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.parkreldis.2010.04.008","article-title":"Trials of neuroprotective therapies for Parkinson\u2019s disease: Problems and limitations","volume":"16","author":"Schulzer","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/mds.28379","article-title":"Seven Solutions for Neuroprotection in Parkinson\u2019s Disease","volume":"36","author":"Devos","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"pyu047","DOI":"10.1093\/ijnp\/pyu047","article-title":"Cellular and molecular mechanisms of action of transcranial direct current stimulation: Evidence from in vitro and in vivo models","volume":"18","author":"Pelletier","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1038\/emboj.2012.170","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease: Molecular mechanisms and pathophysiological consequences","volume":"31","author":"Exner","year":"2012","journal-title":"EMBO J."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Guidetti, M., Bertini, A., Pirone, F., Sala, G., Signorelli, P., Ferrarese, C., Priori, A., and Bocci, T. (2022). Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213775"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Gao, X.Y., Yang, T., Gu, Y., and Sun, X.H. (2022). Mitochondrial Dysfunction in Parkinson\u2019s Disease: From Mechanistic Insights to Therapy. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.885500"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/jmp5040037","article-title":"Effects of Calcium Ion Dyshomeostasis and Calcium Ion-Induced Excitotoxicity in Parkinson\u2019s Disease","volume":"5","author":"Nam","year":"2024","journal-title":"J. Mol. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1002\/ana.410440726","article-title":"Subthalamic nucleus-mediated excitotoxicity in Parkinson\u2019s disease: A target for neuroprotection","volume":"44","author":"Rodriguez","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Barat, E., Boisseau, S., Bouyssi\u00e8res, C., Appaix, F., Savasta, M., and Albrieux, M. (2012). Subthalamic nucleus electrical stimulation modulates calcium activity of nigral astrocytes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041793"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/acschemneuro.8b00356","article-title":"Balancing Apoptosis and Autophagy for Parkinson\u2019s Disease Therapy: Targeting BCL-2","volume":"10","author":"Liu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Rajneesh, C.P., Hsieh, T.H., Chen, S.C., Lai, C.H., Yang, L.Y., Chin, H.Y., and Peng, C.W. (2020). Deep Brain Stimulation of the Pedunculopontine Tegmental Nucleus Renders Neuroprotection through the Suppression of Hippocampal Apoptosis: An Experimental Animal Study. Brain Sci., 10.","DOI":"10.3390\/brainsci10010025"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/brain\/awx296","article-title":"Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson\u2019s disease","volume":"141","author":"Milosevic","year":"2018","journal-title":"Brain"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/NRR.NRR-D-24-01019","article-title":"Neuronal plasticity and its role in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"21","author":"Jahan","year":"2026","journal-title":"Neural Regen. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nurt.2010.07.001","article-title":"Astrocytes and therapeutics for Parkinson\u2019s disease","volume":"7","author":"Rappold","year":"2010","journal-title":"Neurotherapeutics"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/cns.12223","article-title":"Deep brain stimulation: Are astrocytes a key driver behind the scene?","volume":"20","author":"Fenoy","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1007\/s00018-020-03584-x","article-title":"Glial cells in Parkinson\u2019s disease: Protective or deleterious?","volume":"77","author":"Domingues","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.3390\/cimb45050284","article-title":"Insights into Advanced Neurological Dysfunction Mechanisms Following DBS Surgery in Parkinson\u2019s Patients: Neuroinflammation and Pyroptosis","volume":"45","author":"Meng","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Li, Y., Su, Z., Zhai, J., Liu, Q., Wang, H., Hao, J., Tian, X., Gao, J., Geng, D., and Wang, L. (2025). Oligodendrocyte-Specific STAT5B Overexpression Ameliorates Myelin Impairment in Experimental Models of Parkinson\u2019s Disease. Cells, 14.","DOI":"10.3390\/cells14151145"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0079-6123(10)84013-0","article-title":"Neurotrophic factor therapy for Parkinson\u2019s disease","volume":"184","author":"Rangasamy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000511121","article-title":"The Effects of Deep Brain Stimulation of the Subthalamic Nucleus on Vascular Endothelial Growth Factor, Brain-Derived Neurotrophic Factor, and Glial Cell Line-Derived Neurotrophic Factor in a Rat Model of Parkinson\u2019s Disease","volume":"99","author":"Faust","year":"2021","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1523\/JNEUROSCI.2060-16.2017","article-title":"Subthalamic Nucleus Deep Brain Stimulation Employs trkB Signaling for Neuroprotection and Functional Restoration","volume":"37","author":"Fischer","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson\u2019s disease: Molecular mechanisms and therapeutic interventions","volume":"8","author":"Yong","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/cns.14167","article-title":"Deep brain stimulation improves central nervous system inflammation in Parkinson\u2019s disease: Evidence and perspectives","volume":"29","author":"Chang","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Picca, A., Guerra, F., Calvani, R., Romano, R., Coelho-J\u00fanior, H.J., Bucci, C., and Marzetti, E. (2021). Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson\u2019s Disease: Roads to Biomarker Discovery. Biomolecules, 11.","DOI":"10.3390\/biom11101508"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.31083\/j.jin2306114","article-title":"Deep Brain Stimulation Mechanisms in Parkinson\u2019s Disease: Immediate and Long-Term Effects","volume":"23","author":"Pei","year":"2024","journal-title":"J. Integr. Neurosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/bem.22083","article-title":"The epigenetic component of the brain response to electromagnetic stimulation in Parkinson\u2019s Disease patients: A literature overview","volume":"39","author":"Consales","year":"2018","journal-title":"Bioelectromagnetics"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1515\/tnsci-2020-0146","article-title":"Epitranscriptome of the ventral tegmental area in a deep brain-stimulated chronic unpredictable mild stress mouse model","volume":"11","author":"Song","year":"2020","journal-title":"Transl. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","article-title":"Epigenetic targeting of histone deacetylase: Therapeutic potential in Parkinson\u2019s disease?","volume":"140","author":"Harrison","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Alosaimi, F., Boonstra, J.T., Tan, S., Temel, Y., and Jahanshahi, A. (2022). The role of neurotransmitter systems in mediating deep brain stimulation effects in Parkinson\u2019s disease. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.998932"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1109\/TMBMC.2020.3036756","article-title":"Closed-Loop Neuromodulation for Parkinson\u2019s Disease: Current State and Future Directions","volume":"7","author":"Kim","year":"2021","journal-title":"IEEE Trans. Mol. Biol. Multi-Scale Commun."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Wolf, D., Ayon-Olivas, M., and Sendtner, M. (2024). BDNF-Regulated Modulation of Striatal Circuits and Implications for Parkinson\u2019s Disease and Dystonia. Biomedicines, 12.","DOI":"10.20944\/preprints202407.0328.v1"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e00348","DOI":"10.1016\/j.neurot.2024.e00348","article-title":"Neuroscience fundamentals relevant to neuromodulation: Neurobiology of deep brain stimulation in Parkinson\u2019s disease","volume":"21","author":"Davidson","year":"2024","journal-title":"Neurotherapeutics"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"100187","DOI":"10.1016\/j.dscb.2025.100187","article-title":"Exploring the role of neuromodulation in neurodegenerative disorders: Insights from Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"17","author":"Oyovwi","year":"2025","journal-title":"Brain Disord."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1525-1403.2010.00282.x","article-title":"The impact of subthalamic deep brain stimulation on nigral neuroprotection-myth or reality?","volume":"13","author":"Harnack","year":"2010","journal-title":"Neuromodulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00259-006-0257-5","article-title":"Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson\u2019s disease","volume":"34","author":"Lokkegaard","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41531-024-00829-5","article-title":"A framework for translational therapy development in deep brain stimulation","volume":"10","author":"Chen","year":"2024","journal-title":"NPJ Park. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1570159X14666151120123025","article-title":"Current Pharmaceutical Treatments and Alternative Therapies of Parkinson\u2019s Disease","volume":"14","author":"Dong","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-017-0096-2","article-title":"Disease modification and Neuroprotection in neurodegenerative disorders","volume":"6","author":"Cummings","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41582-019-0166-4","article-title":"Biomarkers for closed-loop deep brain stimulation in Parkinson disease and beyond","volume":"15","author":"Bouthour","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Fleming, J.E., Dunn, E., and Lowery, M.M. (2020). Simulation of Closed-Loop Deep Brain Stimulation Control Schemes for Suppression of Pathological Beta Oscillations in Parkinson\u2019s Disease. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.00166"},{"key":"ref_82","first-page":"4945","article-title":"Adaptive Closed-Loop Deep Brain Stimulator Coding Techniques for Target Detections in Parkinson\u2019s","volume":"69","author":"Narsimha","year":"2021","journal-title":"IETE J. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","article-title":"The ongoing pursuit of neuroprotective therapies in Parkinson disease","volume":"11","author":"Athauda","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1212\/WNL.0000000000009946","article-title":"Deep brain stimulation in early-stage Parkinson disease: Five-year outcomes","volume":"95","author":"Hacker","year":"2020","journal-title":"Neurology"},{"key":"ref_85","first-page":"9358153","article-title":"Earlier Intervention with Deep Brain Stimulation for Parkinson\u2019s Disease","volume":"2017","author":"Suescun","year":"2017","journal-title":"Park. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"107860","DOI":"10.1016\/j.neuropharm.2019.107860","article-title":"Modifying the progression of Alzheimer\u2019s and Parkinson\u2019s disease with deep brain stimulation","volume":"171","author":"Jakobs","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Lee, K.S., Clennell, B., Steward, T.G.J., Gialeli, A., Cordero-Llana, O., and Whitcomb, D.J. (2022). Focused Ultrasound Stimulation as a Neuromodulatory Tool for Parkinson\u2019s Disease: A Scoping Review. Brain Sci., 12.","DOI":"10.3390\/brainsci12020289"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4103\/1673-5374.320984","article-title":"Toward future adaptive deep brain stimulation for Parkinson\u2019s disease: The novel biomarker\u2014Narrowband gamma oscillation","volume":"17","author":"Ding","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mds.25337","article-title":"Obstacles to the development of a neuroprotective therapy for Parkinson\u2019s disease","volume":"28","author":"Stocchi","year":"2013","journal-title":"Mov. Disord."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/1\/19\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:14:30Z","timestamp":1766708070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/1\/19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["biomedicines14010019"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14010019","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]}}}